nifedipine has been researched along with Paraneoplastic Syndromes in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Paraneoplastic Syndromes: In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pronk, WG | 1 |
| Baars, JP | 1 |
| De Jong, PC | 1 |
| Westermann, AM | 1 |
| Ohguro, H | 1 |
| Ogawa, K | 1 |
| Maeda, T | 1 |
| Maruyama, I | 1 |
| Maeda, A | 1 |
| Takano, Y | 1 |
| Nakazawa, M | 1 |
2 other studies available for nifedipine and Paraneoplastic Syndromes
| Article | Year |
|---|---|
Some unusual paraneoplastic syndromes. Case 2. Digital ulceration as a paraneoplastic syndrome in ovarian cancer.
Topics: Adenocarcinoma; Female; Fingers; Humans; Middle Aged; Nifedipine; Ovarian Neoplasms; Paraneoplastic | 2003 |
Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Topics: Animals; Antibodies; Antigens, Neoplasm; Calcium Channel Blockers; Calcium-Binding Proteins; Dark Ad | 2001 |